Healthy Skepticism Library item: 6647

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Servier’s multiple misleading promotion
MaLAM Australian News 1996; 4:(1):1-2

Abstract:

MaLAM is making a formal complaint to the Australian Pharmaceutical Manufacturers Association about Servier’s marketing of Coversyl (perindopril) since Servier has not responded to an earlier letter. Misleading promotion of ACE inhibitors leads to doctors switching away from drugs with well-proven efficacy. There are also significant problems with Servier’s promotion of other products that it manufactures.

Keywords:
*analysis/Australia/developed countries/Servier/perindopril/Coversyl/quality of information/ Australian Pharmaceutical Manufacturers Association/ Code of Conduct (Aus)/ ACE inhibitor/MaLAM/Medical Lobby for Appropriate Marketing/INFLUENCE OF PROMOTION: PRESCRIBING, DRUG USE/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES/REGULATION, CODES, GUIDELINES: INDUSTRY SELF-REGULATION